Enterprise Bank & Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$428K Hold
2,306
0.16% 92
2025
Q1
$483K Hold
2,306
0.19% 84
2024
Q4
$410K Buy
2,306
+28
+1% +$5.15K 0.13% 92
2024
Q3
$450K Sell
2,278
-101
-4% -$18.9K 0.14% 83
2024
Q2
$408K Hold
2,379
0.14% 84
2024
Q1
$433K Buy
2,379
+5
+0.2% +$862 0.15% 85
2023
Q4
$368K Buy
+2,374
New +$346K 0.13% 88

Other funds holding ABBV

Enterprise Bank & Trust's ABBV Position: Q2 2025 in Review

Enterprise Bank & Trust held its AbbVie (ABBV) position steady in Q2 2025 at 2,306 shares worth $428K. The position accounts for 0.16% of the portfolio, ranked #92.

Enterprise Bank & Trust first reported a position in ABBV in Q4 2023 and has held it in 7 quarters since. The position peaked at $483K in Q1 2025. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Enterprise Bank & Trust held 2,306 shares of AbbVie worth $428K as of Q2 2025.
  • Enterprise Bank & Trust left its AbbVie share count unchanged in Q2 2025.
  • AbbVie made up 0.16% of Enterprise Bank & Trust's portfolio in Q2 2025, its #92 holding.
  • Enterprise Bank & Trust first reported a position in AbbVie in Q4 2023 and has held it in 7 quarters since.
  • Enterprise Bank & Trust's AbbVie position peaked at $483K in Q1 2025.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.